Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET

Abstract Background Today, the standardized uptake value (SUV) is essentially the only means for quantitative evaluation of static [18F-]fluorodeoxyglucose (FDG) positron emission tomography (PET) investigations. However, the SUV approach has several well-known shortcomings which adversely affect th...

Full description

Bibliographic Details
Main Authors: Frank Hofheinz, Jens Maus, Sebastian Zschaeck, Julian Rogasch, Georg Schramm, Liane Oehme, Ivayla Apostolova, Jörg Kotzerke, Jörg van den Hoff
Format: Article
Language:English
Published: SpringerOpen 2019-03-01
Series:EJNMMI Research
Subjects:
PET
FDG
SUV
SUR
Online Access:http://link.springer.com/article/10.1186/s13550-019-0486-9
id doaj-b0de1f5138de4b48b0b41f6bfa691932
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Frank Hofheinz
Jens Maus
Sebastian Zschaeck
Julian Rogasch
Georg Schramm
Liane Oehme
Ivayla Apostolova
Jörg Kotzerke
Jörg van den Hoff
spellingShingle Frank Hofheinz
Jens Maus
Sebastian Zschaeck
Julian Rogasch
Georg Schramm
Liane Oehme
Ivayla Apostolova
Jörg Kotzerke
Jörg van den Hoff
Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
EJNMMI Research
PET
FDG
Quantification
SUV
SUR
Blood SUV
author_facet Frank Hofheinz
Jens Maus
Sebastian Zschaeck
Julian Rogasch
Georg Schramm
Liane Oehme
Ivayla Apostolova
Jörg Kotzerke
Jörg van den Hoff
author_sort Frank Hofheinz
title Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
title_short Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
title_full Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
title_fullStr Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
title_full_unstemmed Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
title_sort interobserver variability of image-derived arterial blood suv in whole-body fdg pet
publisher SpringerOpen
series EJNMMI Research
issn 2191-219X
publishDate 2019-03-01
description Abstract Background Today, the standardized uptake value (SUV) is essentially the only means for quantitative evaluation of static [18F-]fluorodeoxyglucose (FDG) positron emission tomography (PET) investigations. However, the SUV approach has several well-known shortcomings which adversely affect the reliability of the SUV as a surrogate of the metabolic rate of glucose consumption. The standard uptake ratio (SUR), i.e., the uptake time-corrected ratio of tumor SUV to image-derived arterial blood SUV, has been shown in the first clinical studies to overcome most of these shortcomings, to decrease test-retest variability, and to increase the prognostic value in comparison to SUV. However, it is unclear, to what extent the SUR approach is vulnerable to observer variability of the additionally required blood SUV (BSUV) determination. The goal of the present work was the investigation of the interobserver variability of image-derived BSUV. Methods FDG PET/CT scans from 83 patients (72 male, 11 female) with non-small cell lung cancer (N = 46) or head and neck cancer (N = 37) were included. BSUV was determined by 8 individuals, each applying a dedicated delineation tool for the BSUV determination in the aorta. Two of the observers applied two further tools. Altogether, five different delineation tools were used. With each used tool, delineation was performed for the whole patient group, resulting in 12 distinct observations per patient. Intersubject variability of BSUV determination was assessed using the fractional deviations for the individual patients from the patient group average and was quantified as standard deviation (SD is ), 95% confidence interval, and range. Interobserver variability of BSUV determination was assessed using the fractional deviations of the individual observers from the observer-average for the considered patient and quantified as standard deviations (SD p , SD d ) or root mean square (RMS), 95% confidence interval, and range in each patient, each observer, and the pooled data respectively. Results Interobserver variability in the pooled data amounts to RMS = 2.8% and is much smaller than the intersubject variability of BSUV (SD is = 16%). Averaged over the whole patient group, deviations of individual observers from the observer average are very small and fall in the range [ − 0.96, 1.05]%. However, interobserver variability partly differs distinctly for different patients, covering a range of [0.7, 7.4]% in the investigated patient group. Conclusion The present investigation demonstrates that the image-based manual determination of BSUV in the aorta is sufficiently reproducible across different observers and delineation tools which is a prerequisite for accurate SUR determination. This finding is in line with the already demonstrated superior prognostic value of SUR in comparison to SUV in the first clinical studies.
topic PET
FDG
Quantification
SUV
SUR
Blood SUV
url http://link.springer.com/article/10.1186/s13550-019-0486-9
work_keys_str_mv AT frankhofheinz interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT jensmaus interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT sebastianzschaeck interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT julianrogasch interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT georgschramm interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT lianeoehme interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT ivaylaapostolova interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT jorgkotzerke interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
AT jorgvandenhoff interobservervariabilityofimagederivedarterialbloodsuvinwholebodyfdgpet
_version_ 1725010295273816064
spelling doaj-b0de1f5138de4b48b0b41f6bfa6919322020-11-25T01:48:44ZengSpringerOpenEJNMMI Research2191-219X2019-03-01911810.1186/s13550-019-0486-9Interobserver variability of image-derived arterial blood SUV in whole-body FDG PETFrank Hofheinz0Jens Maus1Sebastian Zschaeck2Julian Rogasch3Georg Schramm4Liane Oehme5Ivayla Apostolova6Jörg Kotzerke7Jörg van den Hoff8PET Center, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-RossendorfPET Center, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-RossendorfCharité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiation OncologyCharité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear MedicineDivision of Nuclear Medicine, Department of Imaging and Pathology, KU/UZ LeuvenKlinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav CarusZentrum für Radiologie und Endoskopie, Abteilung für Nuklearmedizin, Universitätsklinikum Hamburg-EppendorfKlinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav CarusPET Center, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-RossendorfAbstract Background Today, the standardized uptake value (SUV) is essentially the only means for quantitative evaluation of static [18F-]fluorodeoxyglucose (FDG) positron emission tomography (PET) investigations. However, the SUV approach has several well-known shortcomings which adversely affect the reliability of the SUV as a surrogate of the metabolic rate of glucose consumption. The standard uptake ratio (SUR), i.e., the uptake time-corrected ratio of tumor SUV to image-derived arterial blood SUV, has been shown in the first clinical studies to overcome most of these shortcomings, to decrease test-retest variability, and to increase the prognostic value in comparison to SUV. However, it is unclear, to what extent the SUR approach is vulnerable to observer variability of the additionally required blood SUV (BSUV) determination. The goal of the present work was the investigation of the interobserver variability of image-derived BSUV. Methods FDG PET/CT scans from 83 patients (72 male, 11 female) with non-small cell lung cancer (N = 46) or head and neck cancer (N = 37) were included. BSUV was determined by 8 individuals, each applying a dedicated delineation tool for the BSUV determination in the aorta. Two of the observers applied two further tools. Altogether, five different delineation tools were used. With each used tool, delineation was performed for the whole patient group, resulting in 12 distinct observations per patient. Intersubject variability of BSUV determination was assessed using the fractional deviations for the individual patients from the patient group average and was quantified as standard deviation (SD is ), 95% confidence interval, and range. Interobserver variability of BSUV determination was assessed using the fractional deviations of the individual observers from the observer-average for the considered patient and quantified as standard deviations (SD p , SD d ) or root mean square (RMS), 95% confidence interval, and range in each patient, each observer, and the pooled data respectively. Results Interobserver variability in the pooled data amounts to RMS = 2.8% and is much smaller than the intersubject variability of BSUV (SD is = 16%). Averaged over the whole patient group, deviations of individual observers from the observer average are very small and fall in the range [ − 0.96, 1.05]%. However, interobserver variability partly differs distinctly for different patients, covering a range of [0.7, 7.4]% in the investigated patient group. Conclusion The present investigation demonstrates that the image-based manual determination of BSUV in the aorta is sufficiently reproducible across different observers and delineation tools which is a prerequisite for accurate SUR determination. This finding is in line with the already demonstrated superior prognostic value of SUR in comparison to SUV in the first clinical studies.http://link.springer.com/article/10.1186/s13550-019-0486-9PETFDGQuantificationSUVSURBlood SUV